(Q36861180)

16 August 2017

1 reference

title

Treatment of hypertension in patients with diabetes mellitus : relevance of sympathovagal balance and renal function (English)

1 reference

16 August 2017

1

Matthias Weck

1 reference

16 August 2017

publication date

27 June 2007

1 reference

Clinical Research in Cardiology

16 August 2017

published in

1 reference

16 August 2017

volume

96

1 reference

16 August 2017

issue

10

1 reference

16 August 2017

page(s)

707-718

1 reference

https://scigraph.springernature.com/pub.10.1007/s00392-007-0535-7

16 August 2017

exact match

0 references

cites work

Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings.

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0535-7

The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0535-7

Continuous 24-hour assessment of the neural regulation of systemic arterial pressure and RR variabilities in ambulant subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0535-7

Single-unit sympathetic discharge : quantitative assessment in human hypertensive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0535-7

Antihypertensive agent moxonidine enhances muscle glucose transport in insulin-resistant rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0535-7

Divergent Effects of Dihydropyridine and Phenylalkylamine Calcium Channel Antagonist Classes on Autonomic Function in Human Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0535-7

Cardiovascular neural regulation explored in the frequency domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0535-7

State-of-the-art-lecture: Obesity-induced hypertension: new concepts from the emerging biology of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0535-7

Differential effects of captopril and nitrates on muscle sympathetic nerve activity in volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0535-7

Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0535-7

Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0535-7

Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0535-7

I1-imidazoline agonist moxonidine decreases sympathetic nerve activity and blood pressure in hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-007-0535-7

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

12 December 2020

Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure

1 reference

12 December 2020

Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: role of pharmacokinetics

1 reference

12 December 2020

Vagal Cardiac Activity in Essential Hypertension: The Effects of Metoprolol and Ramipril

1 reference

12 December 2020

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Reduced Mortality Associated With the Use of ACE Inhibitors in Patients With Type 2 Diabetes

1 reference

12 December 2020

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis

1 reference

12 December 2020

Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure

1 reference

12 December 2020

Aspects of tolerability of centrally acting antihypertensive drugs

1 reference

12 December 2020

Effect of calcium antagonists on plasma norepinephrine levels, heart rate, and blood pressure

1 reference

12 December 2020

Predicting Cardiovascular Risk Using Conventional vs Ambulatory Blood Pressure in Older Patients With Systolic Hypertension

1 reference

12 December 2020

Moxonidine: a review of its use in essential hypertension

1 reference

12 December 2020

Renal and cardiovascular predictors of 9-year total and sudden cardiac mortality in non-insulin-dependent diabetic subjects.

1 reference

12 December 2020

Autonomic dysfunction in patients with mild heart failure and coronary artery disease and the effects of add-on beta-blockade

1 reference

12 December 2020

Calcium-antagonist drugs

1 reference

12 December 2020

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

12 December 2020

[24-hour blood pressure and ECG monitoring in patients with arterial hypertonia -- importance of silent myocardial ischemia]

1 reference

12 December 2020

A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist

1 reference

12 December 2020

The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?

1 reference

12 December 2020

Persistent albuminuria as an index of diabetic nephropathy in type 2 diabetic patients in Osaka, Japan-incidence, risk factors, prognosis and causes of death

1 reference

12 December 2020

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Baroreflex sensitivity is depressed in microalbuminuric Type I diabetic patients at rest and during sympathetic manoeuvres.

1 reference

12 December 2020

Standards of medical care in diabetes

1 reference

12 December 2020

24-h blood pressure and autonomic function is related to albumin excretion within the normoalbuminuric range in IDDM patients.

1 reference

12 December 2020

Impaired circadian modulation of sympathovagal activity in diabetes. A possible explanation for altered temporal onset of cardiovascular disease

1 reference

12 December 2020

Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus

1 reference

12 December 2020

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

1 reference

12 December 2020

Cardiovascular autonomic function is associated with (micro-)albuminuria in elderly Caucasian sujects with impaired glucose tolerance or type 2 diabetes: the Hoorn Study

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

Hemodynamic regulation during postural tilt assessed by heart rate- and blood-pressure variability combined with impedance cardiography.

1 reference

12 December 2020

Is there a glycemic threshold for impaired autonomic control?

1 reference

12 December 2020

Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions

1 reference

12 December 2020

Calcium antagonists and sympathetic nerve activation: are there differences between classes?

1 reference

12 December 2020

Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).

1 reference

12 December 2020

Microalbuminuria, cardiovascular autonomic dysfunction, and insulin resistance in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Ambulatory blood pressure in the transition from normo- to microalbuminuria. A longitudinal study in IDDM patients

1 reference

12 December 2020

Autonomic neuropathy predicts deterioration in glomerular filtration rate in patients with IDDM.

1 reference

12 December 2020

Considerations in the treatment of insulin resistance and related disorders with a new sympatholytic agent

1 reference

12 December 2020

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

1 reference

12 December 2020

Pharmacology of moxonidine, an I1-imidazoline receptor agonist.

1 reference

12 December 2020

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

12 December 2020

Effects of moxonidine vs. metoprolol on blood pressure and metabolic control in hypertensive subjects with type 2 diabetes

1 reference

12 December 2020

Elevated sympathetic nerve activity in patients with accelerated essential hypertension

1 reference

12 December 2020

Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine

1 reference

12 December 2020

Diabetes and risk of adverse events with calcium antagonists

1 reference

12 December 2020

Effect of verapamil on heart rate variability after an acute myocardial infarction. Danish Verapamil Infarction Trial II.

1 reference

12 December 2020

Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten-year follow-up from the diagnosis

1 reference

12 December 2020

The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program

1 reference

12 December 2020

Prognostic significance of microalbuminuria.

1 reference

12 December 2020

Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM.

1 reference

12 December 2020

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

12 December 2020

Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes.

1 reference

12 December 2020

The obese gene product, leptin: possible role in obesity-related hypertension in adolescents

1 reference

12 December 2020

Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

1 reference

12 December 2020

Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study).

1 reference

12 December 2020

I1-imidazoline-receptor agonists in the treatment of hypertension: an appraisal of clinical experience.

1 reference

12 December 2020

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

12 December 2020

Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II.

1 reference

12 December 2020

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

12 December 2020

Assessment of autonomic function in humans by heart rate spectral analysis.

1 reference

12 December 2020

Additional antiproteinuric effect of ultrahigh dose candesartan: a double-blind, randomized, prospective study

1 reference

12 December 2020

Centrally acting antihypertensives: not obsolete after all

1 reference

12 December 2020

Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group

1 reference

12 December 2020

Sympathetic Overactivity in Hypertensive Patients with Chronic Renal Disease

1 reference

12 December 2020

[Moxonidine vs. captopril in minor to intermediate hypertension. Double-blind study of effectiveness and tolerance]

1 reference

12 December 2020

Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild-to-moderate essential hypertension

1 reference

12 December 2020

Nondipping of nocturnal blood pressure is related to urinary albumin excretion rate in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertension

1 reference

12 December 2020

Moxonidine. A review of its pharmacology, and therapeutic use in essential hypertension

1 reference

12 December 2020

ST-segment depression in hypertensive patients is linked to elevations in blood pressure, pulse pressure and double product by 24-h Cardiotens monitoring

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: novel approach to prevent progression of diabetic nephropathy?

1 reference

12 December 2020

Pharmacodynamic action and pharmacokinetics of moxonidine after single oral administration in hypertension patients

1 reference

12 December 2020

Power spectral analysis of heart-rate variations improves assessment of diabetic cardiac autonomic neuropathy

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

Role of sympathetic nervous system in hypertension and effects of cardiovascular drugs.

1 reference

12 December 2020

Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients

1 reference

12 December 2020

Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)

1 reference

12 December 2020

Differential glucose tolerance in dipper and nondipper essential hypertension: the implications of circadian blood pressure regulation on glucose tolerance in hypertension.

1 reference

12 December 2020

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

12 December 2020

[Prospective evaluation of effect of carvedilol therapy on heart rate variability in patients with dilated cardiomyopathy]

1 reference

12 December 2020

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial

1 reference

12 December 2020

Comparison of verapamil versus felodipine on heart rate variability after acute myocardial infarction.

1 reference

12 December 2020

The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology

1 reference

12 December 2020

Weight loss and the renin-angiotensin-aldosterone system

1 reference

12 December 2020

Early recognition of autonomic dysfunction in microalbuminuria: significance for cardiovascular mortality in diabetes mellitus?

1 reference

12 December 2020

Circadian rhythm of arterial blood pressure and albuminuria in diabetic nephropathy

1 reference

12 December 2020

Effects of antihypertensive therapy on left atrial function.

1 reference

12 December 2020

Enhanced renoprotective effects of ultrahigh doses of irbesartan in patients with type 2 diabetes and microalbuminuria

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Mechanism of sympathoinhibition by imidazolines

1 reference

12 December 2020

Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia

1 reference

12 December 2020

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

1 reference

12 December 2020

Circadian variation of blood pressure in patients with diabetic nephropathy

1 reference

12 December 2020

Safety and tolerability of moxonidine in the treatment of hypertension.

1 reference

12 December 2020

[Retrospective analysis of the incidence of severe hypoglycemia in 458 type 1 diabetic patients].

1 reference

12 December 2020

Treatment of hypertensive patients with diabetes

1 reference

12 December 2020

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis

1 reference

12 December 2020

Short and long term effects of antihypertensive therapy in the diabetic rat

1 reference

12 December 2020

Glucose tolerance and other determinants of cardiovascular autonomic function: the Hoorn Study

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

10.1007/S00392-007-0535-7

Identifiers

DOI

1 reference

16 August 2017

1 reference